News
Rein Therapeutics begins patient dosing in in RENEW phase 2 trial of LTI-03 to treat idiopathic pulmonary fibrosis: Austin, Texas Wednesday, May 28, 2025, 12:00 Hrs [IST] Rein The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback